Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LMAT compared with SYK: revenue, margins and what each company keeps, and the suppliers and customers both name
LMAT
Lemaitre Vascular Inc
Change
Mkt cap
Revenue
Revenue
SYK
Stryker Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
LMAT
Lemaitre Vascular Inc
vs
SYK
Stryker Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
LMAT
2 of 3
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
—
▼
−5.04%
—
Q2 FY26
±7.1%
▼
−25.32%
×3.56
May 6 '26
±7.3%
▼
−1.59%
×0.22
Q1 FY26
±7.6%
▲
+24.41%
×3.21
SYK
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±7.2%
▼
−6.38%
×0.89
Q2 FY26
±6.5%
▼
−6.42%
×0.98
= implied
LMAT realized, solid
SYK realized, hatched
One scale, both sides: full bar = 26%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±5.8%
▼
−6.47%
×1.12
Jan 30 '26
±5.2%
▲
+4.31%
×0.83
LMAT
Lemaitre Vascular Inc
Change
80.96
▼
−3.03%
· post 80.97
Mkt cap
$1.9B
Revenue
$68M
Q3 FY26
Revenue
$250M
FY25
SYK
Stryker Corp
Change
325.40
▼
−2.89%
· post 325.87
Closed
Nov 6 '26
Mkt cap
$124.1B
Revenue
$6.5B
Q3 FY26
Revenue
$25.1B
FY25
vs
Compare
Closed
Nov 6 '26
LMAT
Lemaitre Vascular Inc
vs
SYK
Stryker Corp
80.96
▼
−3.03%
post 80.97
Price
325.40
▼
−2.89%
post 325.87
$1.9B
Mkt cap
$124.1B
Q3 FY26
$68M
Revenue
$6.5B
Q3 FY26
FY25
$250M
Revenue
$25.1B
FY25
Change
Change
LMAT
80.96
▼
−3.03%
vs
SYK
325.40
▼
−2.89%
Closed
Nov 6 '26